James Bates
Overview
A board certified radiation oncologist, James Bates, MD, specializes in the treatment of head and neck cancer, and lymphoma. He treats patients at Emory University Hospital Midtown and Emory Proton Therapy Center.
Dr. Bates received his Medical Degree with Distinction in Community Service from University of Rochester School of Medicine and Dentistry in Rochester, New York where he also completed his internship in internal medicine. He completed his residency in radiation oncology at University of Florida Health/Shands Hospital in Gainesville, Florida.
Dr. Bates' research areas of interest are head and neck cancer, late effects of cancer therapies, and lymphoma. He has authored or co-authored over 30 research articles. He has been a reviewer for International Journal of Radiation Oncology, Biology, and Physics, Practical Radiation Oncology, and American Journal of Clinical Oncology among others.
Academic Appointment
- Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine
Education
Degrees
- MD from University of Rochester
Research
Focus
-
Cardiac Disease, HPV-related Head and Neck Cancer, Geographic Disparities
I have a tripartite research focus: reducing the risk of late effects of cancer therapies (specifically cardiac disease), improving the care of patients with HPV-associated head and neck cancers, and minimizing the geographic disparities in access to cancer care.
Publications
-
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
J Clin Oncol Page(s): JCO2401519
01/08/2025 Authors: Rotz SJ; Stratton K; Leisenring WM; Smith SA; Howell RM; Bates JE; Pappo AS; Neglia JP; Armstrong GT; Turcotte LM -
Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints
Physics and Imaging in Radiation Oncology Volume: 33
01/01/2025 Authors: Nosrat F; Dede C; McCullum LB; Garcia R; Mohamed ASR; Scott JG; Bates JE; McDonald BA; Wahid KA; Naser MA -
Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study.
J Am Acad Dermatol Volume: 91 Page(s): 1125 - 1135
12/01/2024 Authors: Boull C; Chen Y; Im C; Geller A; Sapkota Y; Bates JE; Howell R; Arnold MA; Conces M; Constine LS -
Optimal Timing of Organs-at-Risk-Sparing Adaptive Radiation Therapy for Head- and-Neck Cancer under Re-planning Resource Constraints.
11/04/2024 Authors: Nosrat F; Dede C; McCullum LB; Garcia R; Mohamed ASR; Scott JG; Bates JE; McDonald BA; Wahid KA; Naser MA -
Institution-level Patterns of Care for Early-stage Oropharynx Cancers in the United States.
Am J Clin Oncol Volume: 47 Page(s): 542 - 548
11/01/2024 Authors: Janopaul-Naylor JR; Liu Y; Cao Y; Schlafstein AJ; Steuer C; Patel MR; Bates JE; McDonald MW; Stokes WA -
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J -
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
Head Neck Volume: 46 Page(s): 2167 - 2177
09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC -
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nat Med Volume: 30 Page(s): 2373
08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S -
Proton Pencil Beam Scanning Facilitates the Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry.
Cancers (Basel) Volume: 16
08/01/2024 Authors: Ebadi M; Pankuch M; Boyer S; Chang J; Stevens C; Hall MD; Hasan S; Bates JE; Flampouri S; Kole AJ -
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
JAMA Oncol Volume: 10 Page(s): 896 - 904
07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M